Literature DB >> 22489261

Human immunodeficiency virus infection and the liver.

Megan Crane1, David Iser, Sharon R Lewin.   

Abstract

Liver disease in human immunodeficiency virus (HIV)-infected individuals encompasses the spectrum from abnormal liver function tests, liver decompensation, with and without evidence of cirrhosis on biopsy, to non-alcoholic liver disease and its more severe form, non-alcoholic steatohepatitis and hepatocellular cancer. HIV can infect multiple cells in the liver, leading to enhanced intrahepatic apoptosis, activation and fibrosis. HIV can also alter gastro-intestinal tract permeability, leading to increased levels of circulating lipopolysaccharide that may have an impact on liver function. This review focuses on recent changes in the epidemiology, pathogenesis and clinical presentation of liver disease in HIV-infected patients, in the absence of co-infection with hepatitis B virus or hepatitis C virus, with a specific focus on issues relevant to low and middle income countries.

Entities:  

Keywords:  Human immunodeficiency virus; Liver disease; Low-middle income settings

Year:  2012        PMID: 22489261      PMCID: PMC3321495          DOI: 10.4254/wjh.v4.i3.91

Source DB:  PubMed          Journal:  World J Hepatol


  90 in total

1.  Low frequency of liver enzyme elevation in HIV-infected patients attending a large urban treatment centre in Uganda.

Authors:  P Ocama; B Castelnuovo; M R Kamya; G D Kirk; S J Reynolds; A Kiragga; R Colebunders; D L Thomas
Journal:  Int J STD AIDS       Date:  2010-08       Impact factor: 1.359

2.  Variceal bleeding in an adolescent with HIV diagnosed with hepatoportal sclerosis and nodular regenerative hyperplasia.

Authors:  Israel Kochin; Margret Magid; Ronen Arnon; Angela Glasscock; Nanda Kerkar; Tamir Miloh
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-03       Impact factor: 2.839

Review 3.  Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

Authors:  A Carr; K Samaras; D J Chisholm; D A Cooper
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

Review 4.  Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more....

Authors:  W Wahli; O Braissant; B Desvergne
Journal:  Chem Biol       Date:  1995-05

5.  Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.

Authors:  Barbara H McGovern; Jeremy S Ditelberg; Lynn E Taylor; Rajesh T Gandhi; Katerina A Christopoulos; Stacey Chapman; Beth Schwartzapfel; Emily Rindler; Anne-Marie Fiorino; M Tauheed Zaman; Paul E Sax; Fiona Graeme-Cook; Patricia L Hibberd
Journal:  Clin Infect Dis       Date:  2006-06-22       Impact factor: 9.079

6.  Exacerbation of alcoholic liver injury by enteral endotoxin in rats.

Authors:  P Mathurin; Q G Deng; A Keshavarzian; S Choudhary; E W Holmes; H Tsukamoto
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

7.  HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil.

Authors:  Priscilla Alexandrino-de-Oliveira; Joanna Reis Santos-Oliveira; Maria Elizabeth Cavalheiros Dorval; Francisco das Chagas Brandão Da-Costa; Gracy Regina Oliveira Leite Pereira; Rivaldo Venâncio da Cunha; Anamaria Mello Miranda Paniago; Alda Maria Da-Cruz
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-08       Impact factor: 2.743

8.  Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.

Authors:  Nicolás Merchante; Inés Pérez-Camacho; José A Mira; Antonio Rivero; Juan Macías; Angela Camacho; Jesús Gómez-Mateos; Milagros García-Lázaro; Julián Torre-Cisneros; Juan A Pineda
Journal:  Antivir Ther       Date:  2010

9.  Cryptogenic liver disease in HIV-seropositive men.

Authors:  M H Dinh; V Stosor; S M Rao; F H Miller; R M Green
Journal:  HIV Med       Date:  2009-05-06       Impact factor: 3.180

10.  Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy.

Authors:  Shashi Shrivastav; Tomoshige Kino; Tshaka Cunningham; Takamasa Ichijo; Ulrich Schubert; Peter Heinklein; George P Chrousos; Jeffrey B Kopp
Journal:  Mol Endocrinol       Date:  2007-10-11
View more
  24 in total

1.  Risk factors for liver fibrosis among human immunodeficiency virus monoinfected patients using the FIB4 index in Morocco.

Authors:  Mohamed Tahiri; Mustapha Sodqi; Fatima Ez Zahra Lahdami; Latifa Marih; Hassan Lamdini; Wafaa Hliwa; Ahd Oulad Lahcen; Wafaa Badre; Fouad Haddad; Abdelfetah Chakib; Ahmed Bellabah; Rhimou Alaoui; Kamal Marhoum El Filali
Journal:  World J Hepatol       Date:  2013-10-27

2.  Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis.

Authors:  Raghubendra Singh Dagur; Weimin Wang; Edward Makarov; Yimin Sun; Larisa Y Poluektova
Journal:  J Vis Exp       Date:  2019-09-11       Impact factor: 1.355

3.  Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.

Authors:  Jessica L Castilho; Cathy A Jenkins; Bryan E Shepherd; Sally S Bebawy; Megan Turner; Timothy R Sterling; Vlada V Melekhin
Journal:  J Womens Health (Larchmt)       Date:  2015-03-09       Impact factor: 2.681

4.  Matrix stiffness regulate apoptotic cell death in HIV-HCV co-infected hepatocytes: Importance for liver fibrosis progression.

Authors:  Murali Ganesan; Raghubendra Singh Dagur; Edward Makarov; Larisa I Poluektova; Srivatsan Kidambi; Natalia A Osna
Journal:  Biochem Biophys Res Commun       Date:  2018-04-22       Impact factor: 3.575

5.  Analysis of HIV quasispecies suggests compartmentalization in the liver.

Authors:  Patricia K Penton; Jason T Blackard
Journal:  AIDS Res Hum Retroviruses       Date:  2013-10-25       Impact factor: 2.205

6.  Liver diseases in developing countries.

Authors:  Francesca Cainelli
Journal:  World J Hepatol       Date:  2012-03-27

7.  [Noncirrhotic portal hypertension in a human immunodeficiency virus (HIV) infected adolescent].

Authors:  Aída de Fátima Thomé Barbosa Gouvêa; Daisy Maria Machado; Suênia Cordeiro de Vasconcelos Beltrão; Fabiana Bononi do Carmo; Regina Helena Guedes Motta Mattar; Regina Célia de Menezes Succi
Journal:  Rev Paul Pediatr       Date:  2015-03-27

8.  Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans.

Authors:  Michael C Kew
Journal:  Hepat Mon       Date:  2012-10-30       Impact factor: 0.660

9.  Association of Abnormal Liver Function Parameters with HIV Serostatus and CD4 Count in Antiretroviral-Naive Rwandan Women.

Authors:  Jean Claude Dusingize; Donald R Hoover; Qiuhu Shi; Eugene Mutimura; Emmanuel Rudakemwa; Victorien Ndacyayisenga; Léonard Gakindi; Michael Mulvihill; Jean D'Amour Sinayobye; Emmanuel Musabeyezu; Kathryn Anastos
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-21       Impact factor: 2.205

Review 10.  Liver involvement in human immunodeficiency virus infection.

Authors:  Pankaj Puri; Sandeep Kumar
Journal:  Indian J Gastroenterol       Date:  2016-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.